Fundz

Voyager Therapeutics reported raising $20 Million in an initial SEC Form D filing, from an offering of $20 Million

PUBLIC · VYGRJan 17, 2024

Amount Raised

$20 Million

$20 Million sold, per SEC Form D (first sale Jan 3, 2024)

Round Type

Venture

LexingtonBiotechnologyHealth CareTherapeutics

Quick answer

Voyager Therapeutics raised $20 Million in a funding round, dated January 3, 2024. Voyager Therapeutics is based in Lexington, Massachusetts, United States.

How much did Voyager Therapeutics raise?
Voyager Therapeutics raised $20 Million in a funding round on January 3, 2024.
What does Voyager Therapeutics do?
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases.
Where is Voyager Therapeutics based and how big is it?
Voyager Therapeutics is based in Lexington, Massachusetts, United States. Fundz records about 155 employees.
Who are the decision-makers at Voyager Therapeutics?
Fundz holds 1 contact at Voyager Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Voyager Therapeutics, and when

A new round usually means Voyager Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Voyager Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Voyager Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Voyager Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Voyager Therapeutics

Location

75 Hayden Avenue

Lexington, Massachusetts, United States

About

Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc.; and Sangamo Therapeutics, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Voyager Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Voyager Therapeutics's next move

See what Strategic adds

Voyager Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.